Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00991315 · ClinicalTrials.gov registry record
Collecting and Storing Blood and Tumor Tissue Samples From Patients Undergoing Prostatectomy or Transurethral Resection of the Prostate
A clinical trial, sponsored by Rutgers, The State University of New Jersey.
- Terminated
- Registry status
- 126
- Enrollment target
NCT00991315 is a clinical trial that was terminated before completion, run by Rutgers, The State University of New Jersey. The registered enrollment target is 126 participants.
The verdict
NCT00991315 was terminated before completion, sponsored by Rutgers, The State University of New Jersey.
- TERMINATED
- Registry status
- 126 participants
- Enrollment target
Study Summary
The primary objective of this study is to collect material for study's to assess mechanisms of tumor progression, mechanisms of resistance, isolation of stem cells and biologic markers in tissue, serum and peripheral blood mononuclear cells.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2008-12-12 |
| Est. Completion | 2017-04-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00991315
The ClinicalTrials.gov registry entry for NCT00991315 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00991315 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00991315 about?
NCT00991315 is a clinical study titled "Collecting and Storing Blood and Tumor Tissue Samples From Patients Undergoing Prostatectomy or Transurethral Resection of the Prostate". The primary objective of this study is to collect material for study's to assess mechanisms of tumor progression, mechanisms of resistance, isolation of stem cells and biologic markers in tissue, serum and peripheral blood mononuclear cells.
What is the current status of trial NCT00991315?
This trial is currently terminated. The enrollment target is 126 participants. The study started on 2008-12-12. Estimated completion is 2017-04-10.
Who is sponsoring clinical trial NCT00991315?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.